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Abstract: (1) Objective: Highlight the in vitro effects of 3T3-L1 cell exposure to polychlorinated
biphenyls (PCB118 and 153) or benzo(a)pyrene (BaP) alone or as a cocktail on adipogenesis (ADG)
by focusing on changes in lipid metabolism and inflammatory-related genes expression (INFG)
and ADG-related genes expression (ADGG); (2) Results: Treatment from the early stage of cell
differentiation by BaP alone or in combination with PCBs decreased the expression of some of the
ADGG (PPARγ Glut-4, FAS, Lipin-1a, Leptin, and Adiponectin). BaP enhanced the INFG, especially
MCP-1 and TNFα. Co-exposure to BaP and PCB153 showed a synergistic effect on TNFα and IL6
expression. Treatment with BaP and PCBs during only the maturation period up-regulated the
INFG (IL6, TNFα, CXCL-10 & MCP-1). PCB118 alone also enhanced TNFα, CXCL-10, and PAI-1
expression. The change in MCP-1 protein expression was in agreement with that of the gene. Finally,
the BaP-induced up-regulation of the xenobiotic responsive element (XRE)-controlled luciferase
activity was impaired by PCB153 but not by PCB118; (3) Conclusion: BaP and PCBs down-regulate
a part of ADGG and enhance INFG. The direct regulatory effect of PCBs on both ADGG and
INFG is usually rather lower than that of BaP and synergistic or antagonistic cocktail effects are
clearly observed.
Keywords: polychlorobiphenyls (PCB); polycyclic aromatic hydrocarbons; adipocytes; cocktail effect;
adipogenesis; inflammation; Ah receptor; benzo(a)pyrene
1. Introduction
The global prevalence of type 2 diabetes (T2D) is increasing rapidly, running parallel to the
increase in obesity. Globally, an estimated 422 million adults were living with diabetes in 2014,
compared to 108 million in 1980. The global prevalence (age-standardized) of diabetes has nearly
doubled since 1980, rising from 4.7% to 8.5% in the adult population [1]. This worldwide pandemy
of T2D appears only partly caused by the reduction in physical activity, the adoption of a sedentary
lifestyle and the genetic backgrounds. It has become clear that environmental factors are also involved.
Indeed we are exposed in our environment to numerous chemical compounds, including residues
present in food. Studies assessing their detrimental effects are generally performed on only one
isolated compound. Cocktail effects are poorly studied, while they can lead to additive, potentiative,
or antagonist effects. Therefore, it was not possible to extrapolate the effects of chemical cocktails from
data obtained with isolated compounds only.
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T2D is characterized by a chronic low-grade inflammation, notably of white adipose tissue and
liver. Such an insulin resistance-associated pathology has been recently referred to as ‘metaflammation’.
Obesity induces an increased risk of metabolic diseases, including insulin resistance and T2D [2].
However, exposure to some environmental pollutants either in isolation or in the form of cocktails can
also enhance the risk of T2D. Meta-analyses indeed provide quantitative evidence consistent with the
hypothesis that environmental exposure to polychlorinated biphenyls (PCBs) is a contributing risk
factor for the prevalence of T2D [3,4].
PCBs are organochlorines considered as persistent organic pollutants (POPs). They are very stable
and resistant to a large range of physico-chemical environmental conditions. They are fat-soluble
compounds that bioaccumulate in individuals and are bio-magnified in the food chain. They were
first commercially produced in the United States in 1929 and used widely in capacitors, transformers,
hydraulic fluids, heat transfer fluids, lubricants, plasticizers and as components of surface coatings and
ink. There are 209 possible PCB congeners which are categorized based on structural properties such as
the number of chlorine atoms in the compound. A common classification divides PCBs into dioxin-like
(which are agonists of Ah receptor (AhR)) and nondioxin-like (which are agonists of constitutive
androstane receptor (CAR) or pregnane X receptor (PXR)), based on their structural and toxicological
similarity with the dioxin molecule [5,6]. Adverse effects of PCBs have been well documented in animal
and human studies. These include carcinogenicity, reproductive impairment, neuro-developmental
anomalies, immunologic deficiency, and endocrine adverse effects [7,8]. As mentioned above, PCB
exposure was associated to an increased risk of T2D [3,4], but the molecular mechanisms of this
detrimental effect of PCB are poorly understood. In a previous in vivo work, we have demonstrated
in mice, that adipose tissue is the main target organ affected by metabolic disorders induced by
PCB [9]. In this work, transcriptomic analyses highlighted the down-regulation of two genes involved
in insulin sensitivity and glucose homeostasis: Glut-4 and Lipin-1. Interestingly, we failed to detect
hyperglycemia in mice exposed to PCB118 or PCB153, suggesting that PCB congener alone is not
sufficient to induce by itself a diabetic state.
Human exposure to PCBs occurs through food consumption, mainly fishes (especially when taken
from lakes or rivers containing high levels of PCBs) and also meat. In addition, other compounds
present in food can activate AhR. Among them, Polycyclic Aromatic Hydrocarbons (PAH), such as
benzo(a)pyrene (BaP), are particularly of interest. They activate indeed AhR and are metabolized by
CYP1—genes regulated by AhR pathway—into electrophilic compounds that exert mutagenic and
pro-inflammatory effects [10–12]. Recently, urinary high levels of PAHs biomarkers were found to
be positively associated with diabetes mellitus in humans [13]. Therefore, it appeared advisable to
evaluate the cocktail effect of PAHs and PCBs on adipose tissue, one of the main tissue at the origin of
T2D-associated inflammation.
So, the aim of the present work was to study the in vitro cocktail effects of BaP (the PAH of
reference), and either PCBs-DL (PCB118), or bulky PCBs (PCB153), on adipocyte physiology, using
3T3-L1 cells as a model.
2. Results
2.1. Cytotoxicity and Treatments Procedure
The MTT test led us to demonstrate (see Figures 1 and 2) that, in this cellular model, PCBs exhibit
a low cytotoxic effect, and IC50 for these compounds was reached at the highest concentration studied
(100 µM). Therefore, the experiments were undertaken with non-cytotoxic doses (usually one and
five micromolars) compatible with the human exposures. BaP was used at the final concentration of
one micromolar, since with doses above five micromolars around 10% of cell mortality was observed
(Laboratory unpublished data).
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Figure 1. Treatment schedule of 3T3-L1 cells with benzo(a)pyrene (BaP) and/or polychlorinated 
biphenyls (PCBs) (PCB118 or PCB153) from the induction of differentiation (Time 1: day 2–day 14) or 
after differentiation (Time 2: day 4–day 14) to the maturation state (day 14). Dex: dexamethasone. 
IBMX: 3-isobutyl-1-methylxanthine. 
As reported in Section 4, the experiments focused on the measurement of lipid formation and 
expression of genes involved in the adipogenesis, glucose and lipid homeostasis, inflammation and 
production of adipokines in response to cell treatment by organic pollutants (PCB118, PCB153 and 
BaP) alone or in combination at the onset of the induction process from day 0 (see schedule diagram) 
and during the entire differentiation period or only during the adipocyte differentiation (from D2) 
(Figure 1). Hereafter, these periods of treatment are named respectively “Time 1” and “Time 2”. Some 
control experiments were also carried out on undifferentiated cells reaching 70–80% of confluence. 
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Figure 2. Results of MTT assays performed in “Time 1” and “Time 2” conditions after PCB118 or 
PCB153 exposure. 3T3-L1 cells were incubated with or without PCB118 (one or five micromolars) or 
PCB153 (one or five micromolars) according to the “Time 1” or “Time 2” conditions, and MTT assays 
were performed as described in materials and methods section. 
Figure 1. Treatment schedule of 3T3-L1 cells ith benzo(a)pyrene (BaP) and/or polychlorinated
biphenyls (PCBs) (PCB118 or PCB153) from the induction of di fer tion (Time 1: day 2–day 14)
or aft r differentiation (Time 2: day 4–day 14) to the maturati state (day 14). Dex: dexamethasone.
IBMX: 3-isobutyl-1-methylxanthine.
As reported in Section 4, the experiments focused on the measurement of lipid formation and
expression of gen s involved in the adipogenesis, glucose and lipid hom ostasis, inflammation and
production of adipokines in response to cell treatment by organic pollutants (PCB118, PCB153 and
BaP) alone or in combination at the onset of the induction process from day 0 (see schedule diagram)
and during the entire differentiation period or only during the adipocyte differentiation (from D2)
(Figure 1). Hereafter, these periods of treatment are named respectively “Time 1” and “Time 2”. Some
control experiments were also carried out on undifferentiated cells reaching 70–80% of confluence.
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Figure 2. Results of MTT assays performed in “Time 1” and “Time 2” conditions after PCB118 or 
PCB153 exposure. 3T3-L1 cells were incubated with or without PCB118 (one or five micromolars) or 
PCB153 (one or five micromolars) according to the “Time 1” or “Time 2” conditions, and MTT assays 
were performed as described in materials and methods section. 
Figure 2. Results of MTT assays performed in “Time 1” and “Time 2” conditions after PCB118 or
PCB153 exposure. 3T3-L1 cells were incubated with or without PCB118 (one or five micromolars) or
PCB153 (one or five micromolars) according to the “Time 1” or “Time 2” conditions, and MTT assays
were performed as described in materials and methods section.
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2.2. Effects of PCB118, PCB153 and BaP on Oil Red O Staining of Adipocyte Lipids
In order to evaluate globally the effects of the studied organic pollutants on the differentiation of
3T3-L1 adipocytes, we performed measurements by spectrophotometry of lipid synthesis, using the
oil red O staining method.
When pollutants are used at the early phase of the differentiation process (“Time 1”), we observed
(Figure 3 and Appendix A, Figure A1) that in BaP-treated group, Oil red O staining was markedly
reduced. PCBs alone induced a slight decrease of lipid staining, except in experiments with PCB118 at
five micromolars, in which the effects were comparable to those obtained with BaP. When PCBs were
added mixed with BaP, the results were comparable to those observed with BaP alone.
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Figure 3. Effects of PCB1 8, PCB153 a il Red O” staining of adipocytes ((A) “Time 1”;
(B) “Time 2”). 3T3-L1 cells were incubated with or without PCB118 (one of five micro olars) or PCB153
(one or five micromolars) in the presence or not of BaP (one micro olars) according to the “Time
1” or “Time 2” conditions described in materials and methods. The measurement of cellular lipids
was carried out using the “Oil Red O” staining method as described under materials and methods.
Each incubation condition was carried out in quadriplicate and the experiment was repeated three
times. The values are represented as mean ± SD. n = 4 per group. The level of significance is given by
comparison of treated trials with controls: * p < 0.05; ** p < 0.001; *** p < 0.0001.
Similar results are obtained in “Time 2” treatment but the effect of PCBs was slightly lower while
that of BaP was stronger and the coexposure of cells to both kinds of compounds led to a reduction of
the effect of BaP on lipid formation.
2.3. Effects of PCB118, PCB153 and BaP on CYP1A1 Gene Expression
CYP1A1 i a well-known AhR target gene, and both compounds BaP and PCB118 are potent
AhR agonists.
Addition of organic pollutants at the early stage of the induction process, i.e., “Time 1” led to a
lower induction of CYP1A1 expression than expected (Figure 4): a low induction following treatment
of the cells with BaP and PCB118, and no induction with PCB153. However, when the cells were
co-treated with BaP and PCB118, we observed a potentiation of the CYP1A1 induction and surprisingly,
such a potentiation was also observed in response to the combination of BaP with PCB153.
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Figure 4. Effects of PCB118, PCB153 and BaP in “Time 1” conditions on the expression of genes 
related to adipocyte differentiation, glucose and lipid homeostasis, and inflammation. 3T3-L1 cells 
were incubated with or without PCB118 (one or five micromolars) or PCB153 (one or five 
micromolars) in the presence or not of BaP (one micromolar) according to the “Time 1” conditions 
described in materials and methods. Cells were washed twice with PBS and mRNA extraction and 
qRT-PCR were performed as described under materials and methods. Each incubation condition was 
carried out in quadriplicate and the experiment was repeated three times with similar results. The 
data are mean ± SD. The level of significance is given by comparison of treated trials with controls (n 
= 4 per group): * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. 
Figure 4. Effects of PCB118, PCB153 and BaP in “Time 1” conditions on the expression of genes related
to adipocyte differentiation, glucose and lipid homeostasis, and inflammation. 3T3-L1 cells were
incubated with or without PCB118 (one or five micromolars) or PCB153 (one or five micromolars)
in the presence or not of BaP (one micromolar) according to the “Time 1” conditions described in
materials and methods. Cells were washed twice with PBS and mRNA extraction and qRT-PCR were
performed as described under materials and methods. Each incubation condition was carried out in
quadriplicate and the experiment was repeated three times with similar results. The data are mean
± SD. The level of significance is given by comparison of treated trials with controls (n = 4 per group):
* p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001.
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When pollutants were tested at “Time 2”, only BaP induced significantly the CYP1A1 expression.
Surprisingly, this induction of CYP1A1 was partly repressed by a co-addition of PCB118 or PCB153.
2.4. Effects of PCB118, PCB153 and BaP on the Expression of Genes Related to Adipocyte Differentiation,
Glucose and Lipid Homeostasis
PPARγ is generally referred as the “master regulator” of adipogenesis. This factor is both
necessary and sufficient for the adipogenesis induction. The general program of fat cell differentiation
is coordinated by PPARγ and members of the c/EBP family of transcription factors. c/EBPβ is
induced early during the process of adipogenesis and plays a critical role in activating PPARγ
expression. In fat cells, PPARγ, in cooperation with c/EBPα, binds and regulates the expression
of most adipogenesis-related genes [14].
By adding organic pollutants at the early stage of the induction process, i.e., “Time 1” treatment,
we can see (Figure 4) that BaP repressed markedly the expression of PPARγ gene. As generally reported
in the literature, the down-regulation of PPARγ expression is generally associated to a decrease of the
expression of genes involved in glucose and lipid homeostasis such as Glut-4, Lipin-1a, Lipin-1b, ATGL,
FABP4, FAS, HSL, and SREBP. By contrast, in these same conditions an induction of Glut-1 expression
was observed.
In our experiments, in the “Time 1” treatment conditions, PCB alone caused a slight biphasic effect
on Glut-4 gene expression, which was enhanced at one micromolar and decreased at five micromolars,
while Glut-1 expression was only faintly reduced after treatment using either the highest dose of
PCB118 or the two studied doses of PCB153. The expression of Lipin-1a was down-regulated in a
dose-dependent manner, while that of Lipin-1b was only barely modified by PCB118, but enhanced
with only the lowest dose of PCB153. ATGL expression was also barely modified by PCBs and that of
FABP-4 was slightly reduced in the presence of five micromolars of PCB118, but it was induced by
PCB153. The expression of the FAS gene was also impaired by PCB118 and PCB153, that of HSL was
either not modified or only slighlty reduced, while that of SREBP was impaired by the lowest dose of
PCB118 and the two studied doses of PCB153.
Both, PCB118 and PCB153, enhanced the BaP-induced down-regulation of the expression of
PPARγ, Glut-4, Lipin-1a and Lipin-1b genes, while the two compounds caused opposite effects on Glut-1
expression. In the same way, PCB118 and PCB153 enhanced the BaP-induced decrease of ATGL, FABP4,
FAS, and HSL expression but not that of SREBP.
By adding the different compounds during the adipocyte differentiation, i.e., “Time 2” treatment,
we can see (Figure 5) that PPARγ expression was slightly reduced by BaP and PCB118 alone or by
the mixture of the two compounds. Compared to “Time 1”, in the “Time 2” treatment, the effects of
PCB153 tested alone or mixed with BaP were slightly lower. Similar, but more pronounced effects
were observed concerning the Glut-4 expression, for which treatment with BaP enhanced PCB118
and PCB153-induced effects. Glut-1 expression was poorly modified in response to treatment with
either BaP, PCB118, PCB118 + BaP, or PCB153, while a dose-dependent reduction of the expression
was observed by co-exposure with PCB153 and BaP. The expression of Lipin-1a and Lipin-1b was
dramatically reduced following the treatment with either compounds: BaP, PCB118, or PCB153.
Results obtained in response to a co-exposition were similar to those induced by BaP alone. The
expression of ATGL and FABP4 was not significantly modified by any of the treatments. FAS expression
was poorly modulated by BaP alone but was reduced after exposure to low doses of PCB118 or PCB153.
The BaP-induced decrease of FAS expression was slightly amplified in the case of a co-exposure with
either PCB118 or PCB153.
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Figure 5. Effects of PCB118, PCB153 and BaP in “Time 2” conditions on the expression of genes 
related to adipocyte differentiation, glucose and lipid homeostasis and inflammation. 3T3-L1 cells 
were incubated with or without PCB118 (one or five micromolars) or PCB153 (one or five 
micromolars) in the presence or not of BaP (one micromolar) according to the “Time 2” conditions as 
described in materials and methods. Cells were washed twice with PBS and mRNA extraction and 
qRT-PCR were performed as described under materials and methods. Each incubation condition was 
carried out in quadriplicate and the experiment was repeated three times with similar results. The 
data are mean ± SD. The level of significance is given by comparison of treated trials with controls (n 
= 4 per group): * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. 
Figure 5. Effects of PCB118, PCB153 and BaP in “Time 2” conditions on the expression of genes
related to adipocyte differentiation, glucose and lipid homeostasis and inflammation. 3T3-L1 cells were
incubated with or without PCB118 (one or five micromolars) or PCB153 (one or five micromolars) in the
presence or not of BaP (one micromolar) according to the “Time 2” conditions as described in materials
and methods. Cells were washed twice with PBS and mRNA extraction and qRT-PCR were performed
as described under materials and methods. Each incubation condition was carried out in quadriplicate
and the experiment was repeated three times with similar results. The data are mean ± SD. The level
of significance is given by comparison of treated trials with controls (n = 4 per group): * p < 0.05; **
p < 0.01; *** p < 0.001; **** p < 0.0001.
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2.5. Effects of PCB118, PCB153 and BaP on Gene Expression in Undifferentiated 3T3-L1 Cells
As anticipated, the basal level of expression of genes related to adipogenesis, appeared strongly
lower in undifferentiated 3T3-L1 cells than in cells that were differentiated or being differentiated:
(around ×1/90 for Glut-4, 1/60 for Adiponectin, 1/25 for Lipin-1a and 1/70 for PPARγ). The level of
Leptin appeared lesser reduced (around 1/2.5) (see Appendix A, Figure A2).
2.6. Effects of PCB118, PCB153 and BaP on Expression of Inflammatory Genes
It is now well established now that adipose tissue expresses many pro- and anti-inflammatory
cytokines. The existence of a link between pro-inflammatory cytokines produced by adipose tissue
and insulin resistance factors has been already highlighted [15–19].
Addition of the studied pollutants at the early stage of the induction process (“Time 1”
treatment) prompted an up-regulation of the expression of inflammatory genes (TNFα, IL6) (Figure 4).
A synergistic effect was observed when PCB153 (but not PCB118) and BaP were added together to the
cell culture. Concerning MCP-1 gene (Figure 4), the large enhancement of transcripts, induced by BaP,
was partially antagonized by PCB153 but not by PCB118. Similar results were obtained at the protein
level (Figure 6), except that, concerning the high dose of PCB153 which only slightly induced the
MCP-1 protein secretion. In contrast, the expression of CXCL-10 (Figure 4) was only slightly reduced in
the presence of either BaP or PCB118, but a co-exposure to a mixture of BaP and one or the other PCB
(PCB118 or PCB153) induced a synergistic decrease of the expression. Surprisingly, whatever the kind
of treatment used in “Time 1”, either a low down-regulation or no modification of PAI-1 expression
(Figure 4) was observed.
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Figure 6. MCP1 immunoassay “Time 1”. 3T3-L1 cells were incubated with or without PCB118 (one or
five micromolars) or PCB153 (one or five micromolars) in the presence or not of BaP (one micromolar)
according the “Ti e 1” conditions described in materials and methods. The conditioned medium
was collected and MCP1 peptide was measured by immuno-assay as reported under materials and
methods. Each incubation condition was carried out in triplicate and the experiment was repeated
three times. The values are mean ± SD. The level of significance is given by comparison of treated
trials with controls (n = 4 per group): * p < 0.05; ** p < 0.001; *** p < 0.0001.
The expression of inflammatory genes (TNFα, IL6, CXCL-10, and MCP-1) appeared also
up-regulated in response to BaP dded i “Time 2” treatment, while that of PAI-1 w s repressed
(Figu 5). In this condition of treatment, exposure of cells to PCB118 led also to an enhanc ment
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of TNFα gene expression and a decrease of that of PAI-1, while the exposure of the cells to PCB153
caused a down-regulation of the expression of both CXCL-10 and MCP-1, but induced no change in
the expression of PAI-1. The BaP-induced up-regulation of these genes was hindered by PCB153, while
the BaP-induced down-regulation of PAI-1 was not prevented.
2.7. Effects of PCB118, PCB153 and BaP on the Expression of the Main Genes of Adipokines
Adipokines are signaling molecules secreted by the adipose tissue. Leptin and adiponectin are the
two most abundant adipokines. Leptin is generally referred to as “the hormone of satiety” that helps
to regulate the energy balance by inhibiting hunger [20]. Adiponectin is the most abundant peptide
secreted by adipocytes. The reduction of this secretion plays a central role in obesity-related diseases,
including insulin resistance/T2D and cardiovascular diseases [21].
“Time 1” treatment (Figure 4) by either BaP alone or a mixture of BaP and PCBs, in which
cells were treated during the induction process, led to a very strong repression of both leptin and
adiponectin expression, which was almost totally suppressed. In contrast, in the presence of the
high concentration of PCB118 or PCB153 alone, only a faint down-regulation of the adipokine genes
expression was detected.
However, regarding adiponectin and leptin expression, the effects observed in “Time 1” were not
detected in “Time 2” treatment in which BaP induced only a modest up-regulation of adiponectin
expression (Figure 5), whereas the leptin expression was down-regulated by exposure to either BaP,
BaP + PCB118, or BaP + PCB153, but was poorly modified by exposure to PCB118 or PCB153 alone.
2.8. Summary of the Cocktails Effets of PCB118, PCB153 and BaP and Effects on AhR Transcriptional Activity
The Table 1 sums up qualitatively the synergic or antagonist effects of BaP versus PCB + BaP and
of PCB versus PCB + BaP. The significance of all different synergic and antagonist cocktail effects of
PCB and BaP which are reported in Table 1 and Figures 4 and 5 is presented in Table A1, Appendix A.
Generally, the effects obtained following cell exposure to the studied pollutants, BaP and PCBs, were
more pronounced when they are tested in “Time 1” condition. When cells were co-exposed to BaP
and PCBs, most genes belonging to the adipogenesis process (PPARγ, Lipin-1a, Lipin-1b, SREBP
FAS, and HSL) were synergistically down-regulated in both cell treatment periods. Similarly, PCBs
potentiated the BaP-induced down-regulation of Glut-4. Inversely, inflammatory genes (TNFα, IL6,
MCP-1, adiponectin, and leptin) were synergistically up-regulated at “Time 1”. Other inflammatory
genes such as MCP-1, CXCL-10 and IL6 at “Time 2” or Glut-1 at “Time 1” were antagonistically
regulated by BaP and PCB153.
2.9. Effects of PCB118, PCB153 and BaP on Xenobiotic Responsive Element (XRE)-Controlled Luciferase
Activity
PCB118—a dioxin-like PCB—and BaP are two potent AhR agonists [5], while PCB153—a bulky
PCB—activates the PXR/CAR factors [6]. In order to get some insight on the involvement of AhR
pathway in the mechanism of action of these compounds, cells were transiently transfected with the
reporter plasmid XRE-Luc, in which luciferase expression is driven by AhR, and exposed at “Time 1”.
Results are summarized in Figure 7. As expected, as compared to control, both compounds PCB118
and BaP significantly induced luciferase expression. On the other hand, PCB153 caused by itself a weak
effect, but when added mixed with BaP, this PCB counteracted the BaP-induced luciferase expression.
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Table 1. Summary of synergic or antagonist cocktail effects of BaP and PCBs on genes expression
in “Time 1” and “Time 2”: ↓↓ : down-regulation with BaP and down-regulation with PCBs.
↑↑ : up-regulation with BaP and up-regulation with PCBs. ↓↑ : down-regulation with BaP and
up-regulation with PCBs. ↑↓ : up-regulation with BaP and down-regulation with PCB. Inflammatory
genes are in bold characters. Adipokines are in italic and bold characters. The level of significance
of differences between BaP-treated and PCB-treated assays is * p < 0.05; ** p < 0.01; *** p < 0.001. For
details see the tables of significances (Table A1 in Appendix A).
Treatment and Time
Synergism of BaP and PCB Antagonism of BaP and PCB
↓↓ ↑↑ ↓↑ ↑↓
BaP and
PCB118 Time 1
PPARγ **
Glut-4 ***
Lipin-1a *
Lipin-1b **
ATGL **
FABP-4 **
FAS **
HSL ***
SREBP *
CXCL-10 **
Adiponectin ***
Leptin ****
CYP1A1 **
Glut-1 **
BaP and
PCB118 Time 2
PPARγ *
Glut-4 **
Lipin-1a *
Lipin-1b *
HSL *
PAI-1 **
CYP1A1 * Leptin ** Adiponectin**
BaP and
PCB153 Time 1
PPARγ ***
Glut-4 ***
Lipin-1a **
Lipin-1b ***
ATGL ***
FABP-4 ****
FAS ***
HSL **
CXCL-10 **
Adiponectin ***
CYP1A1 **
TNFα ***
IL6 **
Glut-1 ***
MCP-1 ***
BaP and
PCB153 Time 2
Glut-1 *
Glut-4 **
Lipin-1a *
Lipin-1b *
FAS *
HSL *
PAI-1 **
Leptin **
MCP-1 **
CXCL-10 **
Adiponectin
**
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Figure 7. Effects of PCB118, PCB153 and BaP on hR transcriptional activity. Following transfection
with a luciferase reporter gene c tr lle y a xenobiotic esponsive element (XRE) sequence, cells were
challenged with PCB1 8 (fi i olars) or PCB153 (five micromolars) in the presence or not of BaP
(one micromolar) according to “Time 1” conditions reported under materials nd methods. The values
are represented as mean ± SD. n = 4 per group. The level of significance s given by comparison of
treated trials with controls (n = 4 per g up): * p < 0.05, ** p < 0.01, ** p < 0.001.
3. Discussion
Epidemiological studies have allowed the association of environmental exposure to PCB (mainly
through food, notably fishes) to an increased risk of T2D development [3,4]. Recently, we have studied
the effect of PCBs in mice exposed for one month to PCB118 and/or PCB153 and we have shown that
adipose tissue is the main target organ for PCBs-induced metabolic detrimental effects. In this work,
using transcriptomic analyses, we have highlighted the down-regulation of two genes involved in
insulin sensitivity and glucose homeostasis: Glut-4 and Lipin-1. However, we did not observe any
induction of inflammation target genes, such as pro-inflammatory cytokines and chemokines [9].
Recent studies support a role of adipose tissue and inflammation in the regulation of insulin
signaling pathways. Hotamisligil and colleagues have first demonstrated that infla matory mediators
are involved in insulin signaling pat a s [15]. Adipose tissue acts as a site for the producti n of
inflam atory mediators and adip s IL6, IL1β, TNFα, leptin, resistin, MCP-1, PAI-1,
visfatin and adiponectin [15–19].
In order to clarify the health c f environmental and food co-exposure to PAHs hat
exert mutagenic and pro-inflam atory effects [10–12]. We have studied the cocktail effects of BaP and
PCBs—PCB118 or PCB153, which are a PCB-DL and a bulky PCB respectively—on adipose physiology,
using the 3T3-L1 cell line.
Firstly, we studied the effect of these organic pollutants on the adipose differentiation process,
by measuring the cytosolic lipid content and evaluating Lipin-1a, Lipin-1b, and PPARγ expression.
PPARγ is indeed considered the “master regulator” of adipogenesis [14] and recent data suggest that
Lipin-1 functions as a key regulator of PPARγ activity, through its ability to release co-repressors and
recruit co-activators [22]. The greatest effects were observed, when treatments were carried out during
the differentiation process (“Time 1” treatment), while the effects were weaker when the exposure
was performed on differentiated adipocytes (“Time 2” treatment). Similar results had been obtained
with PCB126 (a PCB-DL) by Gadupudi and coworkers [23], who demonstrated that pre-exposure of
preadipocytes to PCB126 resulted in a significant, dose-dependent reduction in their differentiation state,
an this effect was larger than that observed in cultures treated with PCB126 during the differentiation
process. Our data show that both B P and PCB118 reduce cytop asmic lipid conten ; Lipin-1a, Lipin-1b and
PPARγ expression, whi e PCB153, a the two studied doses, do n-regulates th lipid conte t and Lipin-1a
expression while it nhances PPARγ and Lipin-1b expression. These data are in accordance with previous
in vitro studies performed on adipocytes using PCBs-DL (PCB126) or bulky PCBs (PCB153) [23,24].
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Interestingly, PCB118 and PCB153, strengthened the BaP induced-effect on the decrease of Lipin-1a,
Lipin-1b, and PPARγ expression, while they repressed its effect on lipid content. This repression of Lipin-1a,
and Lipin-1b expression induced by BaP and/or PCBs could result from the induction of pro-inflammatory
cytokines and by the enhancement of endoplasmic reticulum stress. Lipin-1 is indeed a multifunctional
protein which plays a critical role in adipose differentiation, mitochondrial oxidation, and triglyceride
synthesis. Down-regulation of this factor was tightly associated to the insulin resistance in mice and
human [25,26]. Although some cytokines such as TNFα and IL1β reduce adipose Lipin-1 expression [27],
the mechanism by which the expression of Lipin-1 was impaired in adipose tissue in obesity states remains
unclear. Recently, endoplasmic reticulum stress has been shown to be involved in the pathogenesis of
obesity through suppression of the Lipin-1 expression in 3T3-L1 adipocytes [28]. On the other hand,
cytochromes P450, notably those belonging to the CYP1 family, can induce endoplasmic reticulum
stress [29], and interestingly, our results show that combination of BaP and PCB118 induces CYP1A1
expression in adipocytes.
Our results show also that the decrease of lipid content and PPARγ expression is associated with
a decrease of other genes involved in lipid homeostasis, such as FAS, ATGL, HSL, SREBP, and FABP-4.
The effects of BaP were larger than those induced by PCBs alone, which induced similar but lower
effects on gene expression, except for FABP-4, for which expression was enhanced by PCB153. Liver X
receptors (LXRs) are nuclear receptors that control cellular metabolism and modulate the expression
of genes involved in cholesterol and lipid metabolism. Activation of LXR in adipocytes leads to
the induction of the expression of SREBP, FAS, and HSL [30]. PAHs down-regulate FAS and SREBP
expression in HepG2 cells throughout the inhibition, via AhR, of LXR transactivation [31]. Such a
process would probably occur also in adipocytes and so it could explain the observed down-regulation
of FAS, HSL, SREBP induced by BaP and PCB118.
The induction of FABP-4 by PCB153 observed in our study is probably related to the induction of
PPARγ. Indeed, it has been demonstrated that PPARγ binds to A (adipocyte-type)-FABP-PPRE [32]
and up-regulates its expression.
Most mammalian cells import glucose by a process of facilitated diffusion mediated by members
of the Glut family of membrane transport proteins that play a major role in glucose homeostasis.
Therefore we have studied the effect of BaP and/or PCBs on Glut-1 and Glut-4 expression. Our data
demonstrated that, in pre-adipocytes, BaP represses Glut-4 expression and induces that of Glut-1.
The BaP-induced decrease of Glut-4 expression was enhanced by either PCB118 or PCB153, while the
BaP-induced Glut-1 expression was enhanced by PCB118 only. In mature adipocytes, we observed that
BaP and also PCB118 or PCB153 (alone or in combination with the former) decreased Glut-4 expression.
It is established that Glut-4 mediates insulin-stimulated glucose uptake in adipocytes. Under insulin
resistant states, such as obesity and T2D, Glut-4 expression is down-regulated specifically in adipose
tissue but not in skeletal muscle [33]. Glut-1 catalyzes the rate-limiting step in supplying cells of the
central nervous system with glucose, an essential fuel for these cells. Glut-1 is frequently up-regulated
during oncogenesis in many different tissue types, a process that is probably essential for tumors to
grow beyond a size limited by their glycolytic capacity (the Warburg effect) [34]. In brown adipose
tissue, Glut-1 is involved in the norepinephrine-induced glucose uptake [35]. In our data, the main
effects of PAHs and PCBs in adipose tissue on the Glut transporter family was on the Glut-4 isoform.
This observation is in agreement with the usually observed association of the down-regulation of this
gene with insulin resistant states.
T2D and insulin resistance are linked to a chronic low-grade inflammation of adipose tissue [15–19].
Our data show that in pre-adipocytes (“Time 1” treatment), BaP enhanced the expression of
pro-inflammatory cytokines (TNFα, IL6) which was associated with an enhanced production of the
chemokine MCP-1. The effect of PCBs on MCP-1 expression was low, but interestingly the lowest dose
(1 µM) was the more potent. While PCB118 did not modulate the pro-inflammatory effect of BaP, PCB153
enhanced the BaP-induced TNFα and IL6 production. These data are in agreement with the literature.
Studies based indeed on differentiated human THP1 macrophages have led to propose that after the
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binding to some ligands, such as TCDD, AhR activates the EGFR-pathway, leading to ERK1/2 activation,
through which expression of the TNFα gene is up-regulated [36]. In addition, toxic metabolites derived
from AhR ligands, such as BaP, may also activate a range of signaling pathways, including ERK1/2 [37].
The regulation of IL6 expression in response to AhR ligands appears to be rather complex and is depending
on the cell type and the cytokine/inflammatory signal environment. In MCF-7 and CV-1 cells, it has been
demonstrated that AhR plays a role on IL6 expression through the de-repression of the IL6 promoter,
leading to a synergistic IL6 expression in the presence of other inflammatory signals, such as IL1β [38].
Induction of IL1β and IL6 expression in adipose tissue has been recently described, after mice exposure to
PCB153 [39]. It is likely that the de-repression of the IL6 promoter is involved in the BaP- and PCB-induced
up-regulation of IL6 expression. The induction of pro-inflammatory cytokines we have observed, is also
associated to an increase of MCP-1 expression. Similar results have been described in mice exposed to the
PCB-DL, PCB77 [40]. Moreover, MCP-1 is a key chemokine expressed by the adipocytes and plasma level
of this factor positively correlates with the increased adiposity. The secretion of MCP-1 is sufficient to
induce the recruitment and infiltration of macrophages in the adipose tissue which lead to the initiation
of the inflammatory response and the obesity-related insulin resistance [41].
Pro-coagulant and fibrinolytic markers have been proposed as being risk factors for the
development of T2D. When fed with a high-fat/high carbohydrates diet, mice homozygous null
for the PAI-1 gene display ameliorated insulin and glycemic measures and protective effects against
the development of obesity and insulin resistance as compared with wild-type mice. Likewise, early
cross-sectional studies in humans have reported correlations between elevated PAI-1 concentrations
and obesity, insulin resistance, impaired glucose tolerance, and T2D [42]. Our data show that BaP and
PCBs induced no significant modification of PAI-1 expression in pre-adipocytes (“Time 1” treatment).
Inversely, in mature adipocytes (“Time 2” treatment), BaP and PCB118 but not PCB153 down-regulated
PAI-1. This latter data is consistent with a previous study performed in vivo in mice, in which it was
demonstrated that PCB153 slightly enhances PAI-1 blood circulating level [43].
Adipose tissue secretes also specific cytokines, called adipokines, such as the two most abundant:
leptin and adiponectin. Our results show that in pre-adipocytes (“Time 1” treatment), BaP markedly
represses leptin and adiponectin expression. PCBs alone reduce only barely their expression, and
enhance the effect of BaP. Comparable but less pronounced effects were observed when treatment was
performed on mature adipocytes (“Time 2” treatment). Similarly, it has been demonstrated in 3T3-L1
pre-adipocytes, that PCB77 (a PCB-DL) and to a lesser extent PCB153, reduce adiponectin expression [44].
Moreover, recently, it was observed in pig ovarian cells co-cultures, a BaP-induced decrease of
adiponectin secretion and receptors expression [45]. Adiponectin, secreted by the adipocytes, is
considered as an insulin-sensitizing, anti-apoptotic, and anti-inflammatory peptide. Adiponectin
secretion seems to be regulated by local insulin sensitivity [46]. Leptin is involved in the regulation
of food intake through the central nervous system. This adipokine exerts both pro-inflammatory
activity and insulin-sensitizing actions [46]. Chronic leptin replacement therapy has been shown to
reverse liver and muscle insulin resistance and fasting hyperglycaemia in patients displaying a severe
lipodystrophy [47]. Taken together, these data suggested that by inducing a decrease of adiponectin and
leptin expression, BaP and PCBs are also potent to promote the development of insulin resistance states.
The permanent environmental exposition to a range of chemical compounds to which we are subject
makes it advisable to evaluate possible resulting cocktail effects on cell function and health. As mentioned
in Table 1, most genes belonging to adipogenesis (PPARγ, Lipin-1a, Lipin-1b, SREBP FAS, and HSL)
were synergistically down-regulated at “Time 1” or “Time 2” treatment. Similarly, PCBs potentiated
BaP-induced down-regulation of Glut-4. Inversely, inflammatory genes (TNFα, IL6, MCP-1, adiponectin,
and leptin) were synergistically up-regulated at “Time 1”. Other inflammatory genes as MCP-1, CXCL-10
and IL6 at “Time 2” or Glut-1 at “Time 1” were antagonistically regulated by BaP and PCB153. From a
molecular point of view, BaP and PCB118 are potent agonists of AhR [5] and PCB153 activates two other
transcription factors PXR and CAR [6]. In order to get some insight on the involvement of AhR pathway,
cells were transiently transfected with the reporter plasmid XRE-Luc, in which luciferase expression is
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driven by AhR, and exposed to the “Time 1” treatment. BaP largely enhanced luciferase expression,
and PCB118 or PCB153 alone induced only a slight increase. We have observed that PCB153 induces
AhR transcripts, while BaP and PCB118 reduce it (see Figure A3 in Appendix A). When BaP is used in
conjunction with PCB118 we observed an additive effect, inversely PCB153 antagonized in part BaP
effects. CAR and PXR belong to the family of steroid nuclear receptors and in the absence of ligand,
these receptors repress the transcription of target genes via recruitment of the corepressors, SMRT and
N-CoR. In turn, these corepressors recruit various histone deacetylases resulting in an inactive chromatin
state. Hormone binding triggers the release of corepressors and the subsequent association of an array of
coactivators, including SRC-1, CBP/p300 and ASC-2 [48]. Previously, we have demonstrated that retinoids
decrease the CYP1A1 induction [49]. This process is related to the AhR pathway through the release of
the corepressor SMRT by RAR, and its subsequent dimerization with AhR. Probably, such a process is
involved in the observed antagonism effect of PCB153 on BaP-induced luciferase expression. Moreover,
it was recently described that PXR protects from BaP-induced DNA damage, and it can bound AhR at
its DNA-binding domain, and this association may play a role in preventing of the AhR from binding
to its target genes [50]. Inversely, concerning the expression of CYP1A1, TNFα, and IL6, we observed
that PCB153 enhances the effect of BaP in pre-adipocytes (“Time 1” treatment). Interestingly, it has been
described that AhR regulates CAR expression in both murine and human liver, and such a phenomenon
could also occur in adipose tissue [51]. In the same way, PAH such BaP, and their dihydrodiol metabolites,
were able to activate PXR and enhance CYP3A4 expression in human cell lines (HepG2 and HEK-293
cells) [52]. Therefore, the enhancement of BaP-induced effects by PCB153 could be interpreted at least in
part on the one hand by the activation of PXR by BaP and their dihydrodiol metabolites and on the other
hand by the enhancement of CAR expression through the AhR pathway.
Generally, the effects obtained after exposure to BaP and PCBs were more pronounced in
pre-adipocytes (“Time 1” treatment) than in mature one (“Time 2” treatment). These data are
in agreement with the lower level of AhR protein already observed during the ongoing adipose
differentiation in 3T3-L1 cells [53]. As discussed above, AhR activation enhances in adipocytes the
expression of both pro-inflammatory cytokines (TNFα, IL6) and MCP-1 chemokine, which can in
return amplify the inflammatory signal by inducing the recruitment and infiltration of macrophages
in this tissue. However, according to recent studies, the AhR is essential for the differentiation and
activation of T helper 17 (Th17) cells. PAHs, such as BaP, halogenated-dioxins and their congeners,
such as PCB-DL, contribute to the inflammation via the promotion of the Th17 differentiation [54].
Interestingly, SREBP, which is an LXR targeted-type gene, mediates also the suppression of Th17
differentiation by binding to the E-box element found on the IL17 promoter which lead to a physical
interaction with AhR and an inhibition of the AhR-controlled IL17 transcription [55]. Th17 enrichment
has been observed in both adipose tissue of obese subjects and, obese type 2 diabetic patients and
also in adipose tissue-derived stem cells from obese subjects. Such an enhancement of Th17 cells
contribute to adipose tissue inflammation and lead to reduce the insulin response by promoting Th17
and monocyte activation [56]. Therefore the down-regulation of SREBP by BaP and/or PCBs would
promote Th17 differentiation and may reshape the regulation of the inflammation process.
Taken together, these data suggest that PAHs and PCBs-DL can promote T2D through the
modulation of the balance between two kinds of cellular process: on the one hand, inhibition of
adipocyte differentiation and on the other hand, the development of a low grade chronic inflammation
of adipose tissue. This process occurs through targeting the AhR pathway both in adipose tissue
and immune system. We demonstrated that in mice-derived adipose cells, PAHs modulate more
deeply than PCBs the down-regulation of ADGG and the induction of INFG. However, when studying
the cocktail effects, our data suggest that PCB-DL, such as PCB118, enhance in adipose tissue the
BaP-induced effects while, depending on the gene studied, bulky PCB, such as PCB153, increase
or repress them. Therefore, it appears really essential to study the cocktail effects. Studies using a
single pollutant are indeed poorly representative of the environmental context and could conduct
to false leads. Moreover, in vivo, in the context of the entire body, the organs interact with one
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another. For example, thyroid, which regulates metabolic processes essential for normal growth and
development as well as the metabolism steady state in the adult, plays an essential role in adipose
tissue function. Dioxin-like compounds that are potent AhR agonists, has been demonstrated to
affect thyroid endocrine functions by causing hypo-thyroxemia associated to a reduced blood level
of thyroxin (T4). This reduction is at least in part the consequence of some dysfunctions, such as an
increase of thyroxin glucuronidation in liver, a down-regulation in the expression of sodium iodide
symporter (NIS) and cathepsin B in thyrocytes. All this leads to the development of thyroid autoimmune
disorders by modulating immune response through AhR pathway [57,58]. Therefore, it would be of
interest to perform in vivo co-exposition to PAH and PCB in mice to evaluate the consequence in the
main target organs—adipose tissue, liver—and on thyroid function.
4. Materials and Methods
4.1. Chemicals and Reagents
Foetal calf serum (FCS) (‘HyClone’, lot n◦CPB 0054) was from Perbio (Thermo scientific, Brebières,
France). The Dulbecco’s Modified Eagle Medium (DMEM) and newborn bovine serum (NBBS)
lot n◦ S 857 46S0750 were from Dutscher (Brumath, France). The lipofectin reagent and the
luciferase detection kit was from Promega (Charbonnières, France). The following compounds
were from Sigma (L’Isle d’Abeau, France): Benzo-apyrene (BaP), DMSO, phosphate-buffered
saline (PBS), bovine serum albumin (BSA), isobutyl-methylxanthine (IBMX), Insulin (bovine origin),
Dexamethasone (DEX), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium. (MTT) and Oil Red
O reagent (ORO). Proteinase-K was from Invitrogen (Cergy_Pontoise, France), BioRad kit for
protein assays was from Interchim (Montluçon, France), M-MLV Reverse Transcriptase from In
Vitrogen/Thermo-Fischer (Cergy-Pontoise, France), 5× HOT Pol Evagreen® qPCR Mix Plus was from
Euromedex, (Souffelweyersheim, France) PCB118 and PCB153 were purchased from AccuStandard
Inc. (New Haven, CT, USA).
4.2. Cell Culture and Differentiation
The preadipocyte of cloned cell line 3T3-L1, isolated from Swiss strain of mouse embryos, was
obtained from American Type Culture Collection (ATCC). The 3T3-L1 were routinely cultured at 37 ◦C,
in a humid atmosphere of 5% CO2 under sterile condition in 25 or 75 cm2 flask filled with a basic cell
culture medium containing DMEM supplemented with 10% NBBS and 1% penicillin/streptomycin
solution at 5 mg/mL. The medium was changed every four days and the cells are reseeded imperatively
before reaching 50–60% confluence.
Cell differentiation was carried out following seeding of cells in multiwell plates: 24-wells plate
was seeded with 25,000 cells/well or 100,000/well in 6-wells plate. When cells reached 70–80%
confluence, that day is called day 0 and the medium was changed by the FCS-basic medium containing
FCS instead of NBBS. At day 2, the medium was changed by the induction medium (FCS-basic medium
supplemented by 0.5 mM IBMX, 1 µM DEX and 1 µg/mL insulin). At day 4, the medium was replaced
by the differentiation medium (FCS-basic medium containing 1 µg/mL insulin), and this medium are
changed in every three days until day 14 (Figure 1).
4.3. Cell Treatment
In order to test the compounds BaP, PCB118 and PCB153, alone or mixed, these were dissolved in
DMSO at different concentrations. These working solutions were added to the culture medium in order
to reach final concentrations of 1 and 5 µM for PCB118 and PCB153, and 1 µM for BaP, respectively.
The solvent (DMSO) was added in assays in order to reach everywhere the same concentration of
solvent (0.5 µL/mL) in each assay.
According to experiments, PCBs and BaP were incorporated in the culture medium at two
different times: either at the onset of induction period “Time 1” (day 2 to day14) in order to highlight a
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possible impact of PCBs on adipocyte differentiation and maturation or “Time 2” (day 4 to day 14) in
order to evidence an effect of PCBs on only the maturation of adipocytes.
4.4. MTT Test
The MTT test was used to evaluate a possible effect of PCBs and BaP on cell survival and avoid
cytotoxic doses of these compounds.
After cells incubation with MTT for about 3 h at 37 ◦C, the cells, their mitochondria and the violet
precipitates formazan are dissolved in 100% DMSO. The optical density (OD) at 550 nm led to know
the relative amount of alive and active metabolically cells.
4.5. Oil Red O Staining (ORO) and Quantification of Lipids
This method allows to observe the evolution of adipocyte differentiation identified by the
hydrophobic lipid staining in liquid phase. The colored body, called lysochrome, moves from the
solvent where it is located into lipid tissue. The commercial ORO solution is diluted the day before
and extemporaneously filtered according to standard methods [59].
For staining, after removing the culture medium, culture dishes (24 wells plates) were washed
with warm PBS and the cells were fixed with Para-Formaldehyde (4% in PBS) for 30 min and finally
three washes with PBS was carried out and the cells were dried. Then 300 µL of diluted ORO solution
was added in. After incubation for 2 h at 37 ◦C and three times washing with water, cell staining was
extracted in isopropanol (300 µL). The quantification was done by measuring the OD at 492 nm.
In order to express the results in relation to the cellular material, the measured OD is normalized
to the amount of DNA. For this, the cells were lysed using a buffer (100 µL) containing 0.01 M
Tris pH 7.8, 0.2 M NaCl, 0.005 M EDTA, 0.5% Sodium dodecyl sulfate (SDS), supplemented with
20 mg/mL proteinase-K. DNA was quantified by spectrophotometry using the Nanodrop® assay.
(100 µL) containing 0.1 M Tris pH 8.0, 0.2 M NaCl, 0.005 M EDTA, 0.5% Sodium dodecyl sulfate (SDS),
supplemented with 20 mg/mL proteinase-K. DNA was quantified by spectrophotometry using the
Nanodrop® assay.
4.6. Immuno-Detection of MCP-1
MCP-1 detection was carried out on the cell culture medium using the ‘Mouse MCP-1 Elisa Kit’
from Thermo-scientific and according to the instructions of the manufacturer. For assays, cell medium
was usually 4 times diluted and measures were carried out on 100 µL of such dilutions. MCP-1
concentration was found between 4 and 20 ng/mL of culture medium.
4.7. RNA Isolation and qRT-PCR Analyses
Total RNA was extracted from 3T3-L1 cells using Trizol® as the solvent of lysis and quantified
by spectrophotometry. The conversion of RNA to cDNA is carried out in the presence of nucleotides
(dNTPs), random primers, reverse transcriptase (M-MLV Reverse Transcriptase from Invitrogen,
Paris, France) and incubation buffer. The cDNA was used as a template for PCR to amplify the
specific product.
PCR experiments were performed using a LightCycler480 System (Roche, Boulogne-Billancourt,
France) in 96 well-plates. The PCR was performed with 0.4 µM of each primer and 5× HOT Pol
Evagreen® qPCR Mix Plus (Euromedex, Souffelweyersheim, France). Cycling conditions including
initial PCR activation (1 cycle) at 95 ◦C for 15 min and followed by 40 cycles of amplification (15 s
denaturation at 95 ◦C, 20 s primer annealing and 20 s fragment elongation at 72 ◦C). A melt program
was performed at the end of the PCR. The raw fluorescence data were analyzed using LightCycler480
(Roche Diagnostics, Meylan, France). The sequences of primers used for c-DNA amplification by
qPCR are listed in Table 2. Target gene mRNA expression was normalized to β-actin, and data were
quantified using the 2−∆∆Ct method [60].
Int. J. Mol. Sci. 2018, 19, 841 21 of 30
4.8. Transient Transfection and Luciferase Assay
Transient gene expression experiments were performed in 24-well plates according to Vallee
et al., 2004 and Njock et al., 2014 [61,62]. Each well (2 cm2) contained 2 × 105 cells in DMEM
supplemented with 10% FCS. One hour before the transfection, cells were incubated in serum-free
DMEM, then the transfection was carried out as using, for each well, 0.4 mL DMEM containing 0.3 µg
of plasmid DNA construction to be tested including two XRE sequences driving luciferase (LUC) gene
expression (XRE-TK-LUC) that was previously described [63], 0.1 µg of control plasmid driving the
β-galactosidase expression, and 2 µL of lipofectin. Sixteen hours later, the medium was replaced by
1 mL DMEM supplemented with 10% FCS and culture was resumed for twenty four hours. The cells
were then challenged, with or without BaP and PCB, or both compounds, and incubation resumed for
additional twenty four hours. Extracts were prepared using the lysis buffer of the Promega luciferase
kit. Protein content of each assay was determined (BioRad assay kit, Marnes-la-Coquette, France).
Table 2. Sequences of primers used in qRT-PCR analyses. F: forward; R: reverse.
Primers
Sequence (5′-3′)
F R
Mus_Actin β GGAGGGGGTTGAGGTGTT GTGTGCACTTTTATTGGTCTCAA
Mus_AhR TGCACAAGGAGTGGACGA AGGAAGCTGGTCTGGGGTAT
Mus_Cyp1a1 TCTTTTGGGAGGAAGTGGAA TCCATACATGGAAGGCATGA
Mus_PPARγ AAGAGCTGACCCAATGGTTG ACCCTTGCATCCTTCACAAG
Mus_Glut-1 GGAGAAGAAGGTCACCATC GAGTAGTAGAACACAGCATTG
Mus_Glut-4 GAGAGAGCGTCCAATGTC CGAAGATGCTGGTTGAATAG
Mus_Lipin-1a GGTCCCCCAGCCCCAGTCCTT GCAGCCTGTGGCAATTCA
Mus_Lipin-1b CAGCCTGGTAGATTGCCAGA GCAGCCTGTGGCAATTCA
Mus_FABP-4 GATGAAATCACCGCAGACGACA ATTGTGGTCGACTTTCCATCCC
Mus_FAS GTGACCGCCATCTATATCG CTGTCGTCTGTAGTCTTGAG
Mus_ATGL ACCAGCATCCAGTTCAAC CGAAGTCCATCTCTGTAGC
Mus_HSL CTGAGATTGAGGTGCTGTC GGTGAGATGGTAACTGTGAG
Mus_SREBP CAGCACAGCAACCAGAAGC CCTCCTCCACTGCCACAAG
Mus_TNFα ACAAGCCTGTAGCCCACGTCGTAGC AATGACTCCAAAGTAGACCTGCCCGG
Mus_IL6 ACGGCCTTCCCTACTTCAC ACAGGTCTGTTGGGAGTGG
Mus_MCP-1 CATCCACGTGTTGGCTCA GATCATCTTGCTGGTGAATGAGT
Mus_CXCL-10 GCTGCCGTCATTTTCTGC TCTCACTGGCCCGTCATC
Mus_PAI-1 AGGATCGAGGTAAACGAGAGC GCGGGCTGAGATGACAAA
Mus_Leptin CAGGATCAATGACATTTCACACA GCTGGTGAGGACCTGTTGAT
Mus_Adiponectin TGTTCCTCTTAATCCTGCCCA CCAACCTGCACAAGTTCCCTT
Luciferase assays were performed using 30 µg proteins, which was added to the luciferase assay
reagent, according to instructions of the manufacturer (Promega, Charbonnières-les-Bains, France),
and measure of light emission (1 to 5 s) was carried out using a photometer (Berthold, Thoiry, France).
Results were reported as arbitrary light units of luciferase normalized for transfection efficiency relative
to β-galactosidase activity. At least three independent experiments were carried out four times each.
4.9. Statistical Analyses
Statistical analysis was performed using GraphPad Prism software (GraphPad, San Diego, CA,
USA). The intergroup comparisons were obtained with Kruskal–Wallis test followed up by Dunn’s
test. Values were considered statistically different at p < 0.05. The results are presented as mean ± SD.
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Abbreviations
ADG Adipogenesis
ADGG ADG-related genes
AhR Aryl hydrocarbon receptor
ASC-2 Anterior suture cataract 2
ATCC American Type Culture Collection
ATGL Adipose triglyceride lipase
BaP Benzo(a)pyrene
BSA Bovine serum albumin
c/EBP CCAAT/enhancer binding protein
CAR Constitutive androstane receptor
CBP CREB binding protein
cDNA Complementary DNA
CXCL-10 Chemokine (C-X-C motif) ligand 10
CYP1 Cytochrome P450, family 1
CYP1A1 Cytochrome P450 family 1 subfamily A member 1
DEX Dexamethasone
DMEM Dulbecco’s Modified Eagle Medium
dNTP Deoxynucleotide
EDTA Ethylenediaminetetraacetic acid
EGFR Epidermal growth factor receptor
ERK Extracellular regulated MAP kinase
FABP-4 Fatty acid binding protein 4
FAS Fatty acid synthase
FCS Foetal calf serum
Glut-1 Solute carrier family 2 (facilitated glucose transporter), member 1
Glut-4 Solute carrier family 2 (facilitated glucose transporter), member 4
HSL Hormone-sensitive lipase
IBMX Isobutyl-methylxanthine
IC50 Half maximal inhibitory concentration
IL17 Interleukin 17
IL1β Interleukin 1β
IL6 Interleukin 6
INFG Inflammatory-related genes
LUC Luciferase
LXR Liver X receptor
MCP-1 Monocyte chemoattractant protein 1
M-MLV Moloney murine leukemia virus
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium
NBBS New born bovine serum
N-Cor Nuclear receptor corepressor 1
NIS Sodium iodide symporter
OD Optical density
ORO Red oil O reagent
PAH Polycyclic Aromatic Hydrocarbons
PAI-1 Plasminogen activator inhibitor 1, or Serpine1
PBS Phosphate-buffered saline
PBS Phosphate buffered saline
PCB Polychlorinated biphenyl
PCBs-DL PCB-dioxin like
PCR Polymerase chain reaction
Int. J. Mol. Sci. 2018, 19, 841 23 of 30
POP Persistent organic pollutants
PPARγ Peroxisome proliferator-activated receptor gamma
PXR Pregnane X receptor
SD Standard deviation
SDS Sodium dodecyl sulfate
SMRT Nuclear receptor corepressor 2
SRC-1 Steroid receptor coactivator-1
SREBP Sterol regulatory element binding protein
T2D Type 2 diabetes
T4 Thyroxin
Th17 T helper 17
TNFα Tumor necrosis factor alpha
XRE Xenobiotic responsive element
Appendix A
Table A1. Intergroup comparison: the significance of the synergism and antagonism. Significance of
differences of gene expression between assays treated with either BaP only, or with BaP + PCBs in
“Time 1” and “Time 2”. The intergroup comparisons were obtained with Kruskal–Wallis test followed
up by Dunn’s test. The level of significance is * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Genes
for which there is no significant difference are indicated in italics. ns: no significant. Genes for which
there is no significant difference are indicated in bold.
Time 1
Genes BaP vs.BaP + PCB118-1 µM
BaP vs.
BaP + PCB118-5 µM
PCB118-1 µM vs.
BaP + PCB118-1 µM
PCB118-5 µM vs.
BaP + PCB118-5 µM
CYP1A1 * ** ** **
PPARγ * * ** **
Glut-1 ns ns ** **
Glut-4 ns ns *** ***
Lipin-1a * ** ** **
Lipin-1b ns ns ** **
ATGL ns ns ** **
FABP-4 ns ns ** **
FAS * * ** **
HSL ns * *** ***
SREBP ns ns ns *
TNFα ns ns * *
IL-6 ns ns ns **
MCP-1 ns ns *** ***
CXCL-10 ** ** ** **
PAI-1 ns ns ns ns
Adiponectin * * **** ***
Leptin ns ns ** ****
Genes BaP vs.BaP + PCB153-1 µM
BaP vs.
BaP + PCB153-5 µM
PCB153-1 µM vs.
BaP + PCB153-1 µM
PCB153-5 µM vs.
BaP + PCB153-5 µM
CYP1A1 ns * * **
PPARγ ns ns *** ***
Glut-1 * ns ** ***
Glut-4 ns ns **** ***
Lipin-1a ** ** ** **
Lipin-1b ns ns *** **
ATGL ns ns *** ***
FABP-4 ns ns *** ***
FAS * * *** **
HSL ns ns *** ***
SREBP ns ns ns ns
TNFα ns ** * ***
IL-6 ns * ns **
MCP-1 * ns *** ***
CXCL-10 * * ** **
PAI-1 ns ns ns ns
Adiponectin * * *** ***
Leptin ns ns **** ****
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Table A1. Cont.
Time 2
Genes BaP vs.BaP + PCB118-1 µM
BaP vs.
BaP + PCB118-5 µM
PCB118-1 µM vs.
BaP + PCB118-1 µM
PCB118-5 µM vs.
BaP + PCB118-5 µM
CYP1A1 ns * ns *
PPARγ ns * ns ns
Glut-1 ns ns ns ns
Glut-4 ns * ns **
Lipin-1a ns * * *
Lipin-1b ns * * *
ATGL ns ns ns ns
FABP-4 * ns ns ns
FAS * ns ns ns
HSL * ns * ns
SREBP ns ns ns ns
TNFα ns ns ns ns
IL-6 ns ns ns ns
MCP-1 ns ns ns ns
CXCL-10 * ns * *
PAI-1 ns ns ns *
Adiponectin * ** ns **
Leptin ns ns * **
Genes BaP vs.BaP + PCB153-1 µM
BaP vs.
BaP + PCB153-5 µM
PCB153-1 µM vs.
BaP + PCB153-1 µM
PCB153-5 µM vs.
BaP + PCB153-5 µM
CYP1A1 ns ns ns *
PPARγ ns ns ns ns
Glut-1 ns ns * *
Glut-4 * * ** *
Lipin-1a ns ns * *
Lipin-1b ns ns * *
ATGL ns ns ns ns
FABP-4 ns ns ns *
FAS ns * ns *
HSL ns * ns *
SREBP ns ns ns ns
TNFα ns ns ns ns
IL-6 ns * ns ns
MCP-1 * ns * **
CXCL-10 * ** * **
PAI-1 ns ns ** **
Adiponectin * ns ** ns
Leptin ns ns ** *
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(one micromolar). Cells were washed twice with PBS and mRNA extraction and qRT-PCR were 
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Figure A1. Effects of PCB118, PCB153 on “Oil Red O” staining of adipocytes in Time 1
conditions. 3T3-L1 cells were incubated wit or ithout PCB118 (one or five micromolars) or PCB153
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or “Time 2” conditions described in materials and methods. The measurement of cellular lipids was
carried out using the “Oil Red O” staining method as described under materials and methods.
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Comments of Figure A2: As anticipated, the basal level of expression of genes related to adipogenesis
appeared strongly lower in undifferentiated 3T3-L1 cells than in cells that were differentiated or being
differentiated (around ×1/90 for Glut-4, 1/60 for Adiponectin, 1/25 for Lipin-1a and 1/70 for PPARγ). The level of
Leptin appeared lesser reduced (around 1/2.5).
Concerning Glut-4, the low level of expression was slightly increased in response to PCB153 and this increase
was abolished by the co-addition of BaP. Regarding Leptin and Adiponectin, the low level of expression was faintly
further reduced by the co-exposure to BaP and PCB118 and 153. Expression of Lipin-1a and PPARγ was reduced
by the co-exposure to BaP and PCB118 and also, for the expression of PPARγ, by the mix of BaP and PCB153.
Comparison between the changes of genes expression induced by BaP and PCBs in differentiated versus
undifferentiated cells led to the following observations: on the whole, the expression of genes analyzed in
undifferentiated cells was slightly down-regulated by the mix of BaP and PCB but these effects were often at
the limit of the significance and very faint compared to the down-regulation observed in differentiated cells.
In addition, BaP alone induced no effect in undifferentiated cells while a strong decrease of gene expression was
induced in differentiated cells.
These data led to the observation that gene expression was much more affected by the studied pollutants in
differentiated cells compared to undifferentiated cells. It must be emphasized that the effects of these compounds
were strongly enhanced on genes which were induced by the differentiation process.
Int. J. Mol. Sci. 2018, 19, x 26 of 30 
 
Comments of Figure A2: As anticipated, the basal level of expression of genes related to 
adipogenesis appeared strongly lower in undifferentiated 3T3-L1 cells than in cells that were 
differentiated or being differentiated (around ×1/90 for Glut-4, 1/60 for Adiponectin, 1/25 for Lipin-1a 
and 1/70 for PPARγ). The level of Leptin appeared lesser reduced (around 1/2.5). 
Concerning Glut-4, the low level of expression was slightly increased in response to PCB153 
and this increase was abolished by the co-addition of BaP. Regarding Leptin and Adiponectin, the low 
level of expression was faintly further reduced by the co-exposure to BaP and PCB118 and 153. 
Expression of Lipin-1a and PPARγ was reduced by the co-exposure to BaP and PCB118 and also, for 
the expression of PPARγ, by the mix of BaP and PCB153. 
Comparison between the changes of genes expression induced by BaP and PCBs in differentiated 
versus undifferentiated cells led to the following observations: o  the whole, the expression of genes 
analyzed in undifferentiated cells was slightly down-regulated by the mix of BaP and PCB but these 
effects were often at the limit of the significance and very faint compared to the down-regulation 
observed in differentiated cells. In addition, BaP alone induced no effect in undifferentiated cells 
while a strong decrease of gene expression was induced in differentiated cells. 
These data led to the observation that gene expression was much more affected by the studied 
pollutants in differe tiated cells compared to undifferentiated cells. It must be emphasized that the 
effects of these compounds were strongly enhanced on genes which were induced by the differentiation 
process. 
 
Figure A3. Effects of PCB118, PCB153 and BaP in “Time 1” conditions on the expression of AhR. 
3T3-L1 cells were incubated with or without PCB118 (one or five micromolars) or PCB153 (one or 
five micromolars) in the presence or not of BaP (one micromolar) according to the “Time 1” conditions 
described in materials and methods. Cells were washed twice with PBS and mRNA extraction and 
qRT-PCR were performed as described under materials and methods. Each incubation condition was 
carried out in quadriplicate and the experiment was repeated three times with similar results. The 
data are mean ± SD. The level of significance is given by comparison of treated trials with controls (n 
= 4 per group): * p < 0.05; ** p < 0.01. 
Comments of Figure A3: The PCB118-induced decrease of AhR gene expression was abolished 
by the co-exposure to BaP, while this compound alone decreased only faintly the expression. A 
reverse dose-dependent effect is observed with PCB153: indeed, 1 µM of this compound induced an 
enhancement while 5 µM induced a decrease of the expression. Co-exposure to PCB153 and BaP 
tends to abolish the PCB153-induced effect. 
  
Figure A3. Effects of PCB118, PCB153 and BaP in “Time 1” conditions on the expression of AhR.
3T3-L1 cells were incubated with or without PCB118 (one or five micromolars) or PCB153 (one or five
micromolars) in the presence or not of BaP (one micromolar) according to the “Time 1” conditions
described in materials and methods. Cells were washed twice with PBS and mRNA extraction and
qRT-PCR were performed as describ d under materials and methods. Each incubation condition
was car ied out in quadriplicate an the experiment was repeated three times with s milar results.
The data are mean ± SD. The level of significance is given by comparison of treated trials with controls
(n = 4 per group): * p < 0.05; ** p < 0.01.
Comments of Figure A3: The PCB118-induced decrease of AhR gene expression was abolished by the
co-exposure to BaP, while this compound alone decreased only faintly the expression. A reverse dose-dependent
effect is observed with PCB153: indeed, 1 µM of this compound induced an enhancem nt while 5 µM induced a
decrease of the expression. Co-exposure to PCB153 and BaP tends to abolish the PCB153-induced effect.
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